Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 140 users online. 3 members and 137 guests.

Most users ever online was 3,930 at 06:07 PM on 04-20-2019.

117 results in 0.0100 seconds.
Keywords
Members
Tags
update x
  •  

  • Colonial Pipeline provides System Disruption and Operational Update - - May 17, 2021

    Colonial Pipeline provides System Disruption Operational Update - - May 17, 2021 | site |


    (Excerpt of information contained in Colonial Pipeline press release dated: May 17, 2021)

    Media Statement Update: Colonial Pipeline System Disruption
    Operational Update
    Update: Monday, May 17, 5:25 p.m.


    Colonial Pipeline continues to make substantial progress in safely moving other’s product throughout our pipeline system. We can now report that we are transporting refined products (gasoline, diesel and jet fuel) at normal levels and are fully operational. It will take some time for the fuel supply chain to fully catch-up.

    Thank you to all the terminal operators, the truck drivers making deliveries, and all others who are key in helping to complete the fuel delivery supply chain.
    ...
    See more | Go to post

  • Colonial Pipeline provides System Restart and Operational Update Information - - May 13, 2021

    Colonial Pipeline provides System Restart and Operational Update Information - - May 13, 2021 | site |



    (Information contained in Colonial Pipeline press release dated: May 13, 2021)

    Media Statement Update: Colonial Pipeline System Disruption
    System Restart and Operational Update #2
    Update: Thursday, May 13, 4:40 p.m.
    Colonial Pipeline has continued to make substantial progress in safely restarting our pipeline system. We can now report that we have restarted our entire pipeline system and that product delivery has commenced to all markets we serve. Following this restart, it will take several days for the product delivery supply chain to return to normal. Some markets served by Colonial Pipeline may experience, or continue to experience, intermittent service interruptions during this start-up period. Colonial will move as much gasoline, diesel, and jet fuel as is safely possible and will continue to do so until markets
    ...
    See more | Go to post

  • Colonial Pipeline provides System Restart and Operational Update Information

    Colonial Pipeline provides System Restart and Operational Update Information

    Colonial Pipeline provides System Restart and Operational Update Information | site |


    (Information contained in Colonial Pipeline press release dated: May 12, 2021)

    Media Statement Update: Colonial Pipeline System Disruption
    System Restart and Operational Update
    Wednesday, May 12, 5:10 p.m.
    Colonial Pipeline initiated the restart of pipeline operations today at approximately 5 p.m. ET. Following this restart, it will take several days for the product delivery supply chain to return to normal. Some markets served by Colonial Pipeline may experience, or continue to experience, intermittent service interruptions during the start-up period. Colonial will move as much gasoline, diesel, and jet fuel as is safely possible and will continue to do so until markets return to normal. As we initiate our return to service, our primary focus remains safety. As part of this startup process, Colonial will conduct a comprehensive series of pipeline safety assessmen
    ...
    See more | Go to post

  • Excerpt of FDA Coronavirus COVID-19 Update - - - March 12, 2021

    Excerpt of FDA Coronavirus COVID-19 Update - - - March 12, 2021

    Excerpt of U.S. Food and Drug Administration Coronavirus COVID-19 Update: March 12, 2021 | site |



    (Excerpt of information contained in U.S. Food and Drug Administration [FDA] press release dated: March 12, 2021)
    • Today, the FDA issued an Emergency Use Authorization (EUA) for Propofol-Lipuro 1% injectable emulsion for infusion to maintain sedation via continuous infusion in patients greater than 16 years old who require mechanical ventilation in an intensive care unit setting during the COVID-19 public health emergency. Propofol-Lipuro 1% injectable emulsion for infusion is not FDA-approved and has important differences in its formulation compared to FDA-approved
    ...
    See more | Go to post

  • FDA Coronavirus COVID-19 Update - - - March 5, 2021

    FDA Coronavirus COVID-19 Update - - - March 5, 2021

    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: March 5, 2021 | site |


    (Information contained in U.S. Food and Drug Administration [FDA] press release dated: March 5, 2021)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • The FDA sent letters to 25 firms that produce and issue “FDA registration certificates” to medical device companies (including manufacturers, distributors and sellers). In the letters, the FDA is requesting that firms cease producing and issuing such registration certificates. The registration certificates often have the look of an official government document and many display the FDA logo. The FDA does not issue any type of device establishment registration certificate. Registration and listing with FDA does not denote approval or clearance of the establishment or its devices. Some device manufacturers and distributors
    ...
    See more | Go to post

  • Coronavirus COVID-19 Update - - - March 2, 2021

    Coronavirus COVID-19 Update - - - March 2, 2021

    Coronavirus (COVID-19) Update: March 2, 2021 | site |



    (Information contained in U.S. Food and Drug Administration press release dated: March 2, 2021)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • The agency has updated its FDA COVID-19 Response At-A-Glance Summary, which provides a quick look at facts, figures and highlights on the FDA's response efforts.
    • The agency issued an Emergency Use Authorization (EUA) to Quidel for its QuickVue At-Home COVID-19 Test for at-home use with a prescription. The Quidel QuickVue At-Home COVID-19 Test is an antigen test that detects proteins from SARS-CoV-2, the virus that causes COVID-19, from a nasal swab sample and gives a result in 10-15 minutes without needing to send a sample to a laboratory for analysis. The test is authorized for prescription at-home use with a self-collected nasal swab sample
    ...
    See more | Go to post

  • FEMA Supports Vaccine Distribution - - - COVID-19 Response Update

    FEMA Supports Vaccine Distribution - - - COVID-19 Response Update

    Federal Emergency Management Agency Supports Vaccine Distribution: COVID-19 Response Update | site |



    (Information contained in Federal Emergency Management Agency [FEMA] press release dated: March 2, 2021)


    Washington - - FEMA continues its push to speed up vaccinations across the country, supporting states as they open additional community vaccination centers this week. In addition to Pfizer and Moderna, the Johnson & Johnson vaccine will be delivered to three federal pilot community vaccination centers in California, Florida and Texas, helping to bring this unprecedented pandemic to an end. FEMA continues increasing vaccine allocations to states, tribes and territories, ensuring everyone who wants a vaccine can get one. Using data from CDC’s social vulnerability index, the agency is partnering with state leaders to identify community vaccination centers where they will be able to do the most good for the most vulnerable populations. Today, a comm...
    See more | Go to post

  • Coronavirus (COVID-19) Update: February 23, 2021

    Coronavirus (COVID-19) Update: February 23, 2021

    Coronavirus (COVID-19) Update: February 23, 2021 | site |



    (Information contained in U.S. Food and Drug Administration [FDA] press release dated: February 23, 2021)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • Yesterday, the FDA issued guidances for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential future emergence of variants of SARS-CoV-2, the virus that causes COVID-19
    • The FDA issued a safety communication to inform patients and health care providers that pulse oximeters have limitations and a risk of inaccuracy under certain circumstances. The Pulse Oximeter Accuracy and Limitations: FDA Safety Communication provides:
      • Important recommendations for patients and their caregivers on how to use pulse oximeters at home.
      • Recommendations for health
    ...
    See more | Go to post

  • Listeria Outbreak Update - - - CDC Warning

    in Food

    Listeria Outbreak Update - - - CDC Warning

    Listeria Outbreak Update: CDC Warning| site |



    (Information contained in Centers for Disease Control and Prevention [CDC] press release dated: February 24, 2021)

    CDC has updated its food safety alert for a Listeria outbreak linked to queso fresco made by El Abuelito Cheese Inc.: https://www.cdc.gov/listeria/outbrea...-21/index.html

    Key points:
    • CDC has expanded its advice to not eat, sell, or serve any cheese sold under the brand name El Abuelito, in addition to recalled queso fresco cheese sold under the brand names of El Abuelito, Rio Grande, and Rio Lindo. CDC is concerned that any cheese made or handled at this facility could be contaminated and make people sick.
    • Three new illnesses were reported this week. This outbreak has sickened a total of 10 people in four states (Connecticut, Maryland, New York, and Virginia).
    • Nine people have been hospitalized. No deaths have been reported.
    • Interviews with sick people
    ...
    See more | Go to post

  • Coronavirus COVID-19 Update - - - FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants

    Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants | site |



    Suite of Guidances Addresses Vaccines, Diagnostics and Therapeutics


    (Information contained in U.S. Food and Drug Administration [FDA] press release dated: February 22, 2021) Today, the U.S. Food and Drug Administration issued guidances for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential future emergence of variants of SARS-CoV-2, the virus that causes COVID-19. “The FDA is committed to identifying efficient ways to modify medical products that either are in the pipeline or have been authorized for emergency use to address emerging variants,” said Acting FDA Commissioner Janet Woodcock, M.D. “We know the country is eager to return to a new normal and the emergence of the virus variants raises new concerns about the ...
    See more | Go to post

  • Audio Recording of CDC February 12, 2021 Update on COVID-19

    Audio Recording of CDC February 12, 2021 Update on COVID-19

    Audio Recording of Centers for Disease Control and Prevention February 12, 2021 Update on COVID-19 | site |




    (Audio recorded information contained in Centers for Disease Control and Prevention (CDC) press release dated: February 12, 2021)




    Note: This version of the audio recording may contain an initial 35 minutes and 16 seconds of music. If music is heard, please move the progress bar to the 35 minutes and 17 seconds point.

    Also, there may be an audio gap from the 53 minutes and 47 seconds point to the 54 minutes and 25 seconds point.









    Alternate link to audio recording








    Source and credit: Centers...
    See more | Go to post

  • Coronavirus COVID-19 Update - - - February 12, 2021

    Coronavirus COVID-19 Update - - - February 12, 2021

    Coronavirus COVID-19 Update - - - February 12, 2021 | site |




    (Information contained in U.S. Food and Drug Administration [FDA] press release dated: February 12, 2021)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • This week, the FDA posted the webpage, COVID-19 Vaccine Safety Surveillance, which provides an overview of our active and passive systems used to monitor the safety of authorized COVID-19 vaccines. The FDA’s Center for Biologics Evaluation and Research is conducting these surveillance efforts in collaboration with the Centers for Disease Control and Prevention, the Center for Medicare and Medicaid Services, the Department of Veterans Affairs, and other academic and large non-government healthcare data systems.
    ...
    See more | Go to post

  • FACT SHEET - - - Update on USDA Activities to Contain the COVID-19 Pandemic

    FACT SHEET - - - Update on USDA Activities to Contain the COVID-19 Pandemic

    FACT SHEET: Update on USDA Activities to Contain the COVID-19 Pandemic | site |




    USDA Deploys 127 Disaster, Public Health Specialists to Assist with Federal Response


    (Information contained in U.S. Department of Agriculture [USDA] press release dated: February 10, 2021)


    Washington, Feb. 10, 2021 — In January 2021, President Biden released the National Strategy for the COVID-19 Response and Pandemic Preparedness. The plan is driven by science, data, and public health to improve the effectiveness of our nation’s fight against COVID-19 and to restore trust, accountability and a sense of common purpose in our response to the pandemic.

    The National Strategy provides a roadmap to guide America out of the worst public health crisis in a century. It is organized around seven goals:
    1. Restore trust with the American people.
    2. Mount a safe, effective, and comprehensive vaccination campaign.
    3. Mitigate spread through
    ...
    See more | Go to post

  • FEMA Supports Vaccine Distribution - - - COVID-19 Response Update

    FEMA Supports Vaccine Distribution - - - COVID-19 Response Update

    FEMA Supports Vaccine Distribution: COVID-19 Response Update | site |



    (Information contained in Federal Emergency Management Agency [FEMA] press release dated: February 9, 2021)

    Washington - - FEMA has now provided more than $3.15 billion to states, tribes, territories and the District of Columbia for expenses related to COVID-19 vaccination at 100% federal cost share and deployed 752 incident management and 317 incident support staff across the nation to support vaccine centers with federal personnel and technical assistance. Additional FEMA staff across the country are supporting virtually. FEMA is supporting vaccination centers by providing expedited financial assistance, federal equipment and supplies, and deploying federal personnel to states, tribes, territories and other eligible applicants for vaccination efforts. This assistance is processed when a request is submitted. As the number of states with obligations increases, ...
    See more | Go to post

  • Coronavirus COVID-19 - - - FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

    Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 | site |


    (Information contained in U.S. Food and Drug Administration [FDA] press release dated: February 9, 2021)

    Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for bamlanivimab and etesevimab administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) who test positive for SARS-CoV-2 and who are at high risk for progressing to severe COVID-19. The authorized use includes treatment for those who are 65 years of age or older or who have certain chronic medical conditions. In a clinical trial of patients with COVID-19 at high risk for disease progression, a single intravenous infusion of bamlanivimab and etesevimab administered together significantly reduced COVID-19-related hospitalization and death d
    ...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    Colonial Pipeline provides System Disruption and Operational Update - - May 17, 2021
    by Staff Reporter 1
    Colonial Pipeline provides System Disruption Operational Update - - May 17, 2021 | site |


    (Excerpt of information contained in Colonial Pipeline press release dated: May 17, 2021)

    Media Statement Update: Colonial Pipeline System Disruption
    Operational Update
    Update: Monday, May 17, 5:25 p.m.


    Colonial Pipeline continues to make substantial progress in safely moving other’s product throughout our pipeline system. We can now report that we are transporting refined products (gasoline, diesel and jet fuel) at normal levels and are fully operational. It will take some time for the fuel supply chain to fully catch-up.

    Thank you to all the terminal operators, the truck drivers making deliveries, and all others who are key in helping to complete the fuel delivery supply chain.
    ...
    05-18-2021, 06:11 AM
  • Staff Reporter 1
    Colonial Pipeline provides System Restart and Operational Update Information - - May 13, 2021
    by Staff Reporter 1
    Colonial Pipeline provides System Restart and Operational Update Information - - May 13, 2021 | site |



    (Information contained in Colonial Pipeline press release dated: May 13, 2021)

    Media Statement Update: Colonial Pipeline System Disruption
    System Restart and Operational Update #2
    Update: Thursday, May 13, 4:40 p.m.
    Colonial Pipeline has continued to make substantial progress in safely restarting our pipeline system. We can now report that we have restarted our entire pipeline system and that product delivery has commenced to all markets we serve. Following this restart, it will take several days for the product delivery supply chain to return to normal. Some markets served by Colonial Pipeline may experience, or continue to experience, intermittent service interruptions during this start-up period. Colonial will move as much gasoline, diesel, and jet fuel as is safely possible and will continue to do so until markets
    ...
    05-14-2021, 12:55 AM
  • Staff Reporter 1
    Colonial Pipeline provides System Restart and Operational Update Information
    by Staff Reporter 1
    Colonial Pipeline provides System Restart and Operational Update Information | site |


    (Information contained in Colonial Pipeline press release dated: May 12, 2021)

    Media Statement Update: Colonial Pipeline System Disruption
    System Restart and Operational Update
    Wednesday, May 12, 5:10 p.m.
    Colonial Pipeline initiated the restart of pipeline operations today at approximately 5 p.m. ET. Following this restart, it will take several days for the product delivery supply chain to return to normal. Some markets served by Colonial Pipeline may experience, or continue to experience, intermittent service interruptions during the start-up period. Colonial will move as much gasoline, diesel, and jet fuel as is safely possible and will continue to do so until markets return to normal. As we initiate our return to service, our primary focus remains safety. As part of this startup process, Colonial will conduct a comprehensive series of pipeline safety assessmen
    ...
    05-13-2021, 06:16 AM
  • Staff Reporter 1
    Excerpt of FDA Coronavirus COVID-19 Update - - - March 12, 2021
    by Staff Reporter 1
    Excerpt of U.S. Food and Drug Administration Coronavirus COVID-19 Update: March 12, 2021 | site |



    (Excerpt of information contained in U.S. Food and Drug Administration [FDA] press release dated: March 12, 2021)
    • Today, the FDA issued an Emergency Use Authorization (EUA) for Propofol-Lipuro 1% injectable emulsion for infusion to maintain sedation via continuous infusion in patients greater than 16 years old who require mechanical ventilation in an intensive care unit setting during the COVID-19 public health emergency. Propofol-Lipuro 1% injectable emulsion for infusion is not FDA-approved and has important differences in its formulation compared to FDA-approved
    ...
    03-15-2021, 10:40 PM
  • Staff Reporter 1
    FDA Coronavirus COVID-19 Update - - - March 5, 2021
    by Staff Reporter 1
    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: March 5, 2021 | site |


    (Information contained in U.S. Food and Drug Administration [FDA] press release dated: March 5, 2021)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • The FDA sent letters to 25 firms that produce and issue “FDA registration certificates” to medical device companies (including manufacturers, distributors and sellers). In the letters, the FDA is requesting that firms cease producing and issuing such registration certificates. The registration certificates often have the look of an official government document and many display the FDA logo. The FDA does not issue any type of device establishment registration certificate. Registration and listing with FDA does not denote approval or clearance of the establishment or its devices. Some device manufacturers and distributors
    ...
    03-08-2021, 10:10 AM

Menu

Collapse

Menu

Collapse

Working...
X